Gemma is part of the medical writing team at PRMA Consulting where she focuses on writing global value dossiers across a range of therapy areas. Prior to this, she gained over 10 years’ experience researching innovative cancer therapeutics, mainly at a pre-clinical level, including small peptides, oncolytic viruses, and gene therapies.
She has written reports supporting the clinical trial authorization (CTA) of a new drug for a first-in-man study and sections of clinical study reports while working within the biopharmaceutical industry. She also has editorial experience in publishing manuscripts at an oncology journal.
Gemma has a BSc (Hons) in Biochemistry from The University of Nottingham and a PhD in Oncolytic Virotherapy from The University of Surrey.
Outside of work, Gemma enjoys sketching, baking, Pilates, and long walks with her chocolate Labrador.